TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Sonic Healthcare Limited ( (AU:SHL) ) just unveiled an announcement.
Sonic Healthcare Limited announced a change in the director’s interest, specifically regarding Christopher David Wilks. The notice outlines the direct and indirect interests in the company’s securities, including ordinary shares and unlisted options. This change in director’s interest reflects ongoing adjustments in the company’s governance and may impact stakeholder perceptions regarding the company’s strategic direction and leadership stability.
The most recent analyst rating on (AU:SHL) stock is a Hold with a A$24.00 price target. To see the full list of analyst forecasts on Sonic Healthcare Limited stock, see the AU:SHL Stock Forecast page.
More about Sonic Healthcare Limited
Sonic Healthcare Limited operates in the healthcare industry, primarily focusing on providing laboratory and pathology services. The company is known for its comprehensive range of diagnostic services and has a significant presence in the global healthcare market.
Average Trading Volume: 1,425,944
Technical Sentiment Signal: Sell
Current Market Cap: A$10.49B
For an in-depth examination of SHL stock, go to TipRanks’ Overview page.